Showing results (31-40 of 295) with videos related to

Sort By:
Pageof 30
Journal of Thoracic Disease|June 11, 2019
Diagnostic value of ProGRP for small cell lung cancer in different stagesAoran Dong, Jiali Zhang, Xiaobin Chen, et al.
Frontiers in Immunology|June 6, 2022
Tumor-Resident T Cells, Associated With Tertiary Lymphoid Structure Maturity, Improve Survival in Patients With Stage III Lung AdenocarcinomaHua Zhao, Hao Wang, Yu Zhao, et al.
Frontiers in Molecular Biosciences|August 9, 2021
TIM-3 and CEACAM1 are Prognostic Factors in Head and Neck Squamous Cell CarcinomaFan Yang, Ziqing Zeng, Jing Li, et al.
Biological & Pharmaceutical Bulletin|September 2, 2008
Expression and purification of natural N-terminal recombinant bovine pancreatic trypsin inhibitor from Pichia pastorisLili Yang, Wen Dong, Jinchao He, et al.
European Journal of Cell Biology|January 30, 2013
The role of miRNA-29 family in cancerYang Wang, Xinwei Zhang, Hui Li, et al.
Cancer Cell International|February 5, 2013
Combining the negative lymph nodes count with the ratio of positive and removed lymph nodes can better predict the postoperative survival in cervical cancer patientsYing Chen, Lei Zhang, Jing Tian, et al.
International Journal of Cancer|November 29, 2013
The role of phosphoglycerate mutase 1 in tumor aerobic glycolysis and its potential therapeutic implicationsXiangli Jiang, Qian Sun, Hui Li, et al.
The Journal of Pharmacy and Pharmacology|May 22, 2010
Recombinant bovine pancreatic trypsin inhibitor protects the liver from carbon tetrachloride-induced acute injury in miceLili Yang, Wen Dong, Fang Yan, et al.
Cancer Biology & Therapy|January 13, 2012
Fibroblast activation protein: A potential therapeutic target in cancerRui Liu, Hui Li, Liang Liu, et al.
Cancer Immunology, Immunotherapy : CII|January 7, 2012
Therapeutic effect of intratumoral administration of DCs with conditional expression of combination of different cytokinesChun Huang, Rupal Ramakrishnan, Marko Trkulja, et al.
Pageof 30